SE9002732D0 - Product containing growth factor - Google Patents

Product containing growth factor

Info

Publication number
SE9002732D0
SE9002732D0 SE9002732A SE9002732A SE9002732D0 SE 9002732 D0 SE9002732 D0 SE 9002732D0 SE 9002732 A SE9002732 A SE 9002732A SE 9002732 A SE9002732 A SE 9002732A SE 9002732 D0 SE9002732 D0 SE 9002732D0
Authority
SE
Sweden
Prior art keywords
product containing
glutamine
growth factor
containing growth
igf
Prior art date
Application number
SE9002732A
Other languages
English (en)
Inventor
R Kihlberg
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20380209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE9002732(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE9002732A priority Critical patent/SE9002732D0/sv
Publication of SE9002732D0 publication Critical patent/SE9002732D0/sv
Priority to EP91915528A priority patent/EP0547099B1/en
Priority to DK91915528.3T priority patent/DK0547099T3/da
Priority to AT91915528T priority patent/ATE156017T1/de
Priority to DE69127087T priority patent/DE69127087T2/de
Priority to AU84359/91A priority patent/AU648820B2/en
Priority to PCT/SE1991/000558 priority patent/WO1992003155A1/en
Priority to JP3514810A priority patent/JPH06500109A/ja
Priority to ES91915528T priority patent/ES2107470T3/es
Priority to CA002089257A priority patent/CA2089257A1/en
Priority to US07/975,558 priority patent/US5462924A/en
Priority to US08/435,481 priority patent/US5646118A/en
Priority to GR970402693T priority patent/GR3025047T3/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SE9002732A 1990-08-24 1990-08-24 Product containing growth factor SE9002732D0 (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE9002732A SE9002732D0 (sv) 1990-08-24 1990-08-24 Product containing growth factor
US07/975,558 US5462924A (en) 1990-08-24 1991-08-22 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
CA002089257A CA2089257A1 (en) 1990-08-24 1991-08-22 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
AU84359/91A AU648820B2 (en) 1990-08-24 1991-08-22 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
DK91915528.3T DK0547099T3 (da) 1990-08-24 1991-08-22 Vækstfaktor- og glutaminholdigt produkt og anvendelse af vækstfaktoren til behandling af intestinal mucosa
AT91915528T ATE156017T1 (de) 1990-08-24 1991-08-22 Wachstumsfaktor und glutamin enthaltendes produkt und verwendung des wachstumsfaktors zur behandlung der darmschleimhaut
DE69127087T DE69127087T2 (de) 1990-08-24 1991-08-22 Wachstumsfaktor und glutamin enthaltendes produkt und verwendung des wachstumsfaktors zur behandlung der darmschleimhaut
EP91915528A EP0547099B1 (en) 1990-08-24 1991-08-22 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
PCT/SE1991/000558 WO1992003155A1 (en) 1990-08-24 1991-08-22 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
JP3514810A JPH06500109A (ja) 1990-08-24 1991-08-22 発育因子およびグルタミンを含有する生成物および腸内粘膜の治療のための発育因子の使用
ES91915528T ES2107470T3 (es) 1990-08-24 1991-08-22 Producto que contiene factor de crecimiento y glutamina y uso del factor de crecimiento para el tratamiento de la mucosa intestinal.
US08/435,481 US5646118A (en) 1990-08-24 1995-05-05 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
GR970402693T GR3025047T3 (en) 1990-08-24 1997-10-15 Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9002732A SE9002732D0 (sv) 1990-08-24 1990-08-24 Product containing growth factor

Publications (1)

Publication Number Publication Date
SE9002732D0 true SE9002732D0 (sv) 1990-08-24

Family

ID=20380209

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9002732A SE9002732D0 (sv) 1990-08-24 1990-08-24 Product containing growth factor

Country Status (12)

Country Link
US (2) US5462924A (sv)
EP (1) EP0547099B1 (sv)
JP (1) JPH06500109A (sv)
AT (1) ATE156017T1 (sv)
AU (1) AU648820B2 (sv)
CA (1) CA2089257A1 (sv)
DE (1) DE69127087T2 (sv)
DK (1) DK0547099T3 (sv)
ES (1) ES2107470T3 (sv)
GR (1) GR3025047T3 (sv)
SE (1) SE9002732D0 (sv)
WO (1) WO1992003155A1 (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69129267T2 (de) * 1990-02-13 1998-09-10 Gropep Pty. Ltd., Adelaide Methode zur behandlung intestinaler krankheiten
US5679771A (en) * 1990-02-13 1997-10-21 Gropep Pty. Ltd. Method for treating intestinal diseases
DK0607278T3 (da) * 1991-10-07 2002-06-17 Brigham & Womens Hospital Fremgangsmåde til forstærkning af tarmabsorption
JPH06510065A (ja) * 1992-06-08 1994-11-10 カイロン　コーポレーション 成長因子ｉｇｆ−ｉおよび／またはｉｇｆ−ｉｉの用法
NZ260309A (en) * 1992-06-08 1997-07-27 Pharmacia Ab Substituted For K Use of 1gf-2 for prevention or treatment of nutritional or gastrointestinal disorders and promoting neonatal growth
DK25493D0 (da) * 1993-03-09 1993-03-09 Novo Nordisk As A method of treating a mammal with a biologically active compound
AU696167B2 (en) * 1993-10-29 1998-09-03 Trustees Of Boston University Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents
GB9512100D0 (en) * 1995-06-14 1995-08-09 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
US5814308A (en) * 1996-03-26 1998-09-29 Zhang; Ke Methods for the treatment of gastrointestinal tract disorders
EP0875155A1 (en) * 1997-05-01 1998-11-04 N.V. Nutricia Peri-operative drink
WO1999040883A2 (en) 1998-02-11 1999-08-19 Faller Douglas V Compositions and methods for the treatment of cystic fibrosis
WO2001024812A1 (en) * 1999-10-06 2001-04-12 N.V. Nutricia USE OF TRANSFORMING GROWTH FACTOR β AND GROWTH FACTORS IN THE TREATMENT AND PREVENTION OF DISEASES OF THE INTESTINAL MUCOSA
DE10057290B4 (de) 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
EP1262188A1 (en) * 2001-05-22 2002-12-04 Centre National De La Recherche Scientifique (Cnrs) Improved neuronal gene transfer
US20030099722A1 (en) * 2001-10-09 2003-05-29 Baxter Jeffrey H. Methods and compositions for providing glutamine
NZ539139A (en) * 2002-10-08 2007-11-30 Abbott Lab Methods and compositions for providing glutamine
SE526711C2 (sv) * 2003-01-31 2005-10-25 Probi Ab Nya stammar av Bifidobacterium med förmåga att överleva i magtarmkanalen och producera glutamin in vivo, samt kompositioner och användningar därav
WO2007014167A2 (en) * 2005-07-22 2007-02-01 Five Prime Therapeutics, Inc. Compositions for and methods of treating epithelial diseases with growth factors
WO2009154463A2 (en) * 2008-06-20 2009-12-23 Stichting Top Institute Food And Nutrition Butyrate as a medicament to improve visceral perception in humans
US20110086869A1 (en) 2009-09-24 2011-04-14 The Trustees Of Boston University Methods for treating viral disorders
WO2011072086A1 (en) 2009-12-08 2011-06-16 Hemaquest Pharmaceuticals, Inc. Methods and low dose regimens for treating red blood cell disorders
WO2011113013A2 (en) 2010-03-11 2011-09-15 Hemaquest Pharmaceuticals, Inc. Methods and compositions for treating viral or virally-induced conditions
JP2022536256A (ja) 2019-05-31 2022-08-15 ヴィラクタ サブシディアリー，インク． ヒストンデアセチラーゼ阻害剤を用いてウイルス関連癌を治療する方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
WO1987003806A1 (en) * 1985-12-18 1987-07-02 Veech Richard L Parenteral nutrition therapy with amino acids
JP2573976B2 (ja) * 1986-01-09 1997-01-22 ブリガム・アンド・ウイメンズ・ホスピタル 低カロリ−状態での窒素保持のための成長ホルモンの使用
EP0346429B1 (en) * 1987-12-24 1994-12-28 Gropep Pty. Ltd. Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
US5258287A (en) * 1988-03-22 1993-11-02 Genentech, Inc. DNA encoding and methods of production of insulin-like growth factor binding protein BP53
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
DK657689D0 (da) * 1989-12-22 1989-12-22 Novo Nordisk As Middel med biologisk virkning paa tarmslimhinden
DE69129267T2 (de) * 1990-02-13 1998-09-10 Gropep Pty. Ltd., Adelaide Methode zur behandlung intestinaler krankheiten

Also Published As

Publication number Publication date
CA2089257A1 (en) 1992-02-25
EP0547099B1 (en) 1997-07-30
GR3025047T3 (en) 1998-01-30
ATE156017T1 (de) 1997-08-15
DE69127087T2 (de) 1998-01-15
DK0547099T3 (da) 1998-03-09
ES2107470T3 (es) 1997-12-01
DE69127087D1 (de) 1997-09-04
AU648820B2 (en) 1994-05-05
AU8435991A (en) 1992-03-17
US5462924A (en) 1995-10-31
WO1992003155A1 (en) 1992-03-05
JPH06500109A (ja) 1994-01-06
US5646118A (en) 1997-07-08
EP0547099A1 (en) 1993-06-23

Similar Documents

Publication Publication Date Title
SE9002732D0 (sv) Product containing growth factor
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
ATE73657T1 (de) Verwendung von gamma-linolensaeure und verwandten verbindungen zur herstellung eubnes arzneimittels zur behandlung von endometriose.
HU9502174D0 (en) Aminoacid derivatives, medicaments containing these compounds and process for preparing the same
MY132626A (en) CARBAZOLYL-SUBSTITUTED ETHANOLAMINES AS SELECTIVE ß-3 AGONISTS
DE3669103D1 (de) Ibuprofen enthaltendes arzneimittel.
IE901673L (en) Enzymatic removal of a protein amino-terminal sequence
AU7305196A (en) Compound on a base of nitrogen monoxide used as a medication
DE69317433D1 (de) Ungesättigte aliphatische dicarbonsäuren
DE69719931D1 (de) Verwendung von Acetylcystein zur Herstellung eines Arzneimittels zur Behandlung von chronischen Geschwüren
HU895785D0 (en) Process for the preparation of compositions and medical preparations containing acid-resistent fibroplast growth activator for treating gastrointestinal ulcer
KR910007858A (ko) 초기-촉진 및 향상된 진통제로서의 s(+)-이부프로펜-l-아미노산 및 s(+)-이부프로펜-d-아미노산
DK0389035T3 (da) Farmaceutisk præparat der indeholder en farmaceutisk egnet bærer og forbindelsen med strukturen (7alfa,17alfa)-17-hydroxy-7-methyl-19-nor-17-pregn-5-(10)-en-20-yn-3-on
ATE69164T1 (de) Arzneimittel zur behandlung von uraemie.
DE3684514D1 (de) Verwendung von penicillamin zur behandlung von immunmangelkrankheiten.
ATE187648T1 (de) Zusammensetzungen enthaltend lipoprotein- associated-coagulation-inhibitor (laci) zur herstellung eines medikaments zur behandlung von akuten oder chronischen enzündungen
DE59902666D1 (de) Edelfosin zur behandlung von hirntumoren
PL320342A1 (en) Thrombin inhibitor containing infusion solution, stable during storage
EP0486045A3 (en) S(+)-phenyl-alkanoic acids and alpha-amino acid containing complexes
DK468486D0 (da) Piroxicamholdigt laegemiddel
ZA93275B (en) Pseudopeptide compounds having bradykinin-antagonist activity, process for preparing them and pharmaceutical compositions containing them.
DE69028204D1 (de) Verfahren zur behandlung von unfruchtbarkeit und dafür verwendbares mittel
DK708488D0 (da) Faktor i praeparat
UA28288A (uk) Спосіб лікування шизофренії
HU9200363D0 (en) Process for the production of novel salts of 2-(2,6-dichloranilyno)-phenyl-acetic acid and medical preparations containing such active agents